Learning how the brain takes out its trash may help decode neurological diseases

August 29, 2013
Credit: University of Michigan

Imagine that garbage haulers don't exist. Slowly, the trash accumulates in our offices, our homes, it clogs the streets and damages our cars, causes illness and renders normal life impossible.

Garbage in the brain, in the form of , must also be removed before it accumulates, because it can cause both rare and common , such as Parkinson's. Now, University of Michigan researchers are a leap closer to decoding the critical process of how the brain clears dead cells, said Haoxing Xu, associate professor in the U-M Department of Molecular, Cellular and Developmental Biology.

A new U-M study identified two critical components of this cell clearing process: an essential protein, TRPML1, that helps the so-called garbage collecting cells, called microphages or microglia, to clear out the dead cells; and alipid molecule, which helps activate TRPML1 and the process that allows the microphages to remove these dead cells.

Moreover, the Xu lab identified a synthetic chemical compound that can activate TRPML1. Because this chemical compound ultimately helps activate this cell-clearing process, it provides a that could help combat these neurological diseases.

"This is clearly a drug target," Xu said. "What this paper picks out is exactly what is going wrong in this process."

The video will load shortly
Animation of calcium channels that regulate the clearing of cell debris. Credit: University of Michigan

Scientists began by looking at a very rare neurodegenerative disease called Type IV Mucolipidosis, a childhood neurodegenerative disease characterized by multiple disabilities.

Xu's group found that lack of TRPML1 function, which is the channel through which calcium is released from the lysosome—the cell's recycling center—into the microphage cells, contributes to these . If this calcium channel doesn't work, calcium cannot be released, and dead cells aren't removed, Xu said. The synthetic stimulates the TRPML1 calcium channel to release the calcium into the cell.

Further, dead cells "are bad for live cells," Xu said. An excess of dead cells leads the macrophage cells to also kill healthy neurons necessary for neurological function, which in turn can lead to these neurodegenerative diseases.

There are many neurodegenerative diseases, some very rare and some more common, such as Parkinson's and ALS. The common thread among them is the dearth of live and functioning neurons, which prevents the neurological system from carrying out normal functions, Xu said.

Thus, identifying a lipid molecule and also chemical compounds that stimulates proper function of the TRMPL1 function could revolutionize the treatment of these .

The next step in Xu's research is to test how these general observations are helpful to the neurological diseases and whether the compound is effective in animal models of neurological diseases.

The paper, "A TRP channel in the lysosome regulates large particle phagocytosis via focal exocytosis," appears Aug. 29 online in Developmental Cell.

Explore further: Biologists find potential drug that speeds cellular recycling

Related Stories

New target to stop cancer's spread discovered

January 30, 2013

Disrupting a key interaction between two types of proteins in cells inhibits the spread of cancerous cells, providing researchers with a new pathway toward developing cancer-fighting drugs, according to new findings by Georgia ...

Scientists identify ALS disease mechanism

August 28, 2013

Researchers have tied mutations in a gene that causes amyotrophic lateral sclerosis (ALS) and other neurodegenerative disorders to the toxic buildup of certain proteins and related molecules in cells, including neurons. The ...

Recommended for you

Artificial beta cells

December 8, 2016

Researchers led by ETH Professor Martin Fussenegger at the Department of Biosystems Science and Engineering (D-BSSE) in Basel have produced artificial beta cells using a straightforward engineering approach.

Key regulator of bone development identified

December 8, 2016

Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes—a condition known as brachydactyly. The discovery was made by researchers at Penn State ...

Researchers question lifelong immunity to toxoplasmosis

December 8, 2016

Medical students are taught that once infected with Toxoplasma gondii—the "cat parasite"—then you're protected from reinfection for the rest of your life. This dogma should be questioned, argue researchers in an Opinion ...

TET proteins drive early neurogenesis

December 7, 2016

The fate of stem cells is determined by series of choices that sequentially narrow their available options until stem cells' offspring have found their station and purpose in the body. Their decisions are guided in part by ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.